Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in MYGN — Myriad Genetics Inc

CIK 1692234 Seattle, WA
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,178,826
+$407,744 QoQ
Shares Held
206,450
+20.5% QoQ
Ownership
0.216%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 196 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,196,770,888 across 31 Diagnostics & Research names. MYGN ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DHR
Danaher Corp /De/
 1,063,156 $202,509,948
2 TMO
Thermo Fisher Scientific Inc.
 337,909 $169,414,050
3 MTD
Mettler Toledo International Inc/
 122,114 $156,001,846
4 IDXX
Idexx Laboratories Inc /De
 230,683 $121,440,751
5 ICLR
Icon PLC
 599,198 $104,086,679
6 A
Agilent Technologies, Inc.
 749,294 $99,528,714
7 NTRA
Natera, Inc.
 165,589 $44,949,128
8 LH
Labcorp Holdings Inc.
 141,635 $39,657,800

All Filings in MYGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,178,826 206,450
2026-03-31 $771,082 171,352
2025-12-31 $1,027,416 167,060
2025-09-30 $1,252,102 173,182
2025-06-30 $437,425 82,378
2024-09-30 $108,299 3,954
2024-06-30 $82,503 3,373
2024-03-31 $660 31
2023-12-31 $593 31
2023-06-30 $15,484 668
2023-03-31 $15,517 668
2022-12-31 $606,952 41,830
2022-09-30 $798,115 41,830
2022-06-30 $764,629 42,082
2022-03-31 $1,060,466 42,082
2021-12-31 $1,889,550 68,462
2021-09-30 $1,498,835 46,418
2021-06-30 $1,962,103 64,163
2021-03-31 $3,692,458 121,263
2020-12-31 $2,989,519 151,215
2020-09-30 $4,115,475 315,604
2020-06-30 $2,419,930 213,398
2020-03-31 $3,028,666 211,647